Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $96.5000 (-2.82%) ($91.0000 - $99.7000) on Fri. Mar. 20, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.92% (three month average) | RSI | 75 | Latest Price | $96.5000(-2.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 5.7% a day on average for past five trading days. | Weekly Trend | CAPR advances 18.1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(7%) VT(7%) XLF(7%) EEM(6%) EWI(6%) | Factors Impacting CAPR price | CAPR will decline at least -4.46% in a week (0% probabilities). VIXM(-5%) TLT(-4%) GLD(-3%) SLV(-2%) SHY(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.46% (StdDev 8.92%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $91.46(5.51%) | 10 Day Moving Average | $83.13(16.08%) | 20 Day Moving Average | $73.54(31.22%) | To recent high | -5.9% | To recent low | 183.8% | Market Cap | $1.901b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |